Borosil Ltd · NSE:BOROLTD

Borosil — Q2 FY22 Earnings Presentation

39 slides from Borosil's earnings presentation, Nov 15, 2021

  1. Slide 1: Letter to exchanges: presentation on Q2 and H1 FY22 performance

    BOROSII: Borosil - i m ited em, l2:i> rM-::>mc~L:2=27L. ~q;:r;:d .ic CoQCre:te OfrE: E;-&z ~E~. ~·~ -4: • o5l, ;-r:la - +tl z.;. .:~ c.~l:(l .or7J~£~ J 6 :;F4 E x rc d@ ~rcs1.·: :rn 'fl ~.., November 15, 2021 The DCS -CRD BSE Limited National Stock Exchange of India Ltd Corporate Relationship Depart

  2. Slide 2: Borosil Limited - Investor Presentation Q2FY22

    Borosil Limited - Investor Presentation Q2FY22 Borosil Investor presentation - Q2FY22 01

  3. Slide 3: Safe harbour statement

    Safe harbour statement “This investor presentation has been prepared by Borosil Limited (“Borosil” or “Company”) on a strictly Borosil Investor presentation - Q2FY22 02

  4. Slide 4: About Borosil

    About Borosil Brand with a years of Borosil 50+year legacy Market Leader- Microwavable Kitchenware in India (Consumer Products) Market Leader- Laboratory Glassware Borosil Investor presentation - Q2FY22 03

  5. Slide 5: Vision

    Vision To be the most customer-centric company in India Borosil Investor presentation - Q2FY22 04

  6. Slide 6: Re-Imagining Consumer

    Re-Imagining Consumer Glass Products Consumer Brands Company Company Occasional Use Daily Use (Dinnerware, (Microwavable) Storage, Appliances) - Single Brand Adding brands - - General Trade General Trade Modern Trade E-Commerce Borosil Investor presentation - Q2FY22 05

  7. Slide 7: Three Brands

    Three Brands Single Brand BOROSIL BOROSIL LabQuest Klasspack Lab Glassware Lab Glassware only Lab Instruments Pharma Packaging Domestic Business Domestic Business International Business Borosil Investor presentation - Q2FY22 06

  8. Slide 8: Journey over last 8 years

    Journey over last 8 years Sales CAGR: 20% CAGR: 29% 585 90 2020-21 2020-21 135 2012-13 12 2012-13 Borosil Investor presentation - Q2FY22 07

  9. Slide 9: Financial Overview Q2 FY22 (consolidated)

    Financial Overview Q2 FY22 (consolidated) INR Crore Q2 FY20 Q2 FY21 Q2 FY22 Growth % Net Sales 174.40 139.39 221.83 59.1% EBITDA 31.45 21.67 50.99 135.3% EBITDA 21.67 51.42 137.3% (Before exceptional items) 31.45 EBITDA (%) 18.03% 15.55% 23.18% EBIT 21.79 13.39 42.83 220.0% (Before exceptional items

  10. Slide 10: Financial Overview H1 FY22 (consolidated)

    Financial Overview H1 FY22 (consolidated) INR Crore H1 FY20 H1 FY21 H1 FY22 Growth % Net Sales 303.37 195.49 359.72 84.0% EBITDA 54.64 20.14 70.41 249.6% EBITDA 54.64 23.75 76.88 223.7% (Before exceptional items) EBITDA (%) 18.01% 12.15% 21.37% EBIT 35.77 7.54 59.80 693.2% (Before exceptional items)

  11. Slide 11: Category wise sales (Consumerware)

    Category wise sales (Consumerware) INR Crore Category Q2 FY21 Q2 FY22 Growth % H1 FY21 H1 FY22 Growth % Glassware 30.42 40.69 33.8% 38.78 63.08 62.7% Non Glassware 36.89 49.45 34.0% 44.13 78.40 77.6% Opalware 27.76 67.00 141.4% 31.84 99.40 212.2% Total Consumerware 95.07 157.14 65.3% 114.75 240.88 1

  12. Slide 12: Category wise sales (Scientific)

    Category wise sales (Scientific) INR Crore Category Q2 FY21 Q2 FY22 Growth % H1 FY21 H1 FY22 Growth % Laboratory Glassware 28.12 37.05 31.8% 48.35 65.24 34.9% Lab Instrumentation 3.26 4.99 52.8% 5.72 9.20 60.9% Pharma Packaging 12.94 22.66 75.1% 26.67 44.40 66.5% Total Scientific 44.32 64.69 46.0% 8

  13. Slide 13: ROCE (Consolidated)

    ROCE (Consolidated) INR Crore H1 FY22 Shareholders' Funds 722.36 Less : Intangible Assets (Goodwill) (67.67) Tangible Net Worth 654.69 Add : Defferred Tax Liability 28.21 Add : Total Debt 4.40 Capital Employed 687.29 Less : Investments (188.74) Operating Capital Employed 498.55 PBT (Before Exception

  14. Slide 14: Consumer Division

    Consumer Division Borosil Investor presentation - Q2FY22 13

  15. Slide 15: Storage, Cooking & Serving needs of a modern kitchen

    Storage, Cooking & Serving needs of a modern kitchen Cook Serve Store Cut, Chop, Cook, Bake, Grind, Mix Toast, Grill • Contemporary • • Everyday Use • • • • • Borosil Investor presentation - Q2FY22 14

  16. Slide 16: Consumer Products

    Consumer Products Market Growth % Glass Microwaveables 100 10% Tumblers 440 10% Storage 15% to 20% Hydra Range 1100 10% Opalware 900 15% to 20% 15% Domestic Appliances 9000 10% Note : Market size, growth & share are internal estimates Borosil Investor presentation - Q2FY22 15

  17. Slide 17: Consumer Products Division Growth Theme

    Consumer Products Division Growth Theme Make in India - Enhance/build manufacturing capacity for Opal Glass and Borosilicate Glass New product development To promote Borosil glassware for daily use To make Glass affordable for Mass Consumer Borosil Investor presentation - Q2FY22 16

  18. Slide 18: Borosil - Ally of Progressive Homemaker

    Borosil - Ally of Progressive Homemaker #Morning Preps, Chai, Breakfast, 6 AM Appliances Storage Cookware Dinnerware #Lunch 9 AM Husband, #Dinner Prep, Kids Evening Tea, 9 PM Dinner Serving Lunch Box Heat & Serve Wet storage 6 PM #Social meetings, hi tea, Travel, Workout Borosil Investor presentatio

  19. Slide 19: Trade Partners

    Trade Partners Borosil Investor presentation - Q2FY22 18

  20. Slide 20: Trade partner logos

    www.ifbappliances.com ..•••• .•..•........ : ..... . . • ..... • BOSCH \0\TIMES ~ WALLACE ~ PHARMACEUTICALS PVT. LTD. lnduslnd Bank INTERNET ALKEN rwocKHAI?DT Wf~s qtenma~k A dose of life sPHARMA A new way for a new world Borosil Investor presentation - Q2FY22 19

  21. Slide 21: Growth Pillars

    Growth Pillars Domestic Appliances Expand Range Borosil Investor presentation - Q2FY22 20

  22. Slide 22: Category gaining salience

    Category gaining salience Larah FY21 revenue INR 141.05 cr Borosil Investor presentation - Q2FY22 21

  23. Slide 23: Storage Range

    Storage Range Thoughtful Products creating a new pillar of growth Borosil Investor presentation - Q2FY22 22

  24. Slide 24: Domestic Appliances New Engine of Growth

    Domestic Appliances New Engine of Growth Large market with growth accelerated post Covid Opportunity to create a high quality mass premium range leveraging the Borosil brand Higher category penetration helps to expand the existing retail network Commenced without investments in manufacturing assets

  25. Slide 25: Medium-Term Thrust Areas

    Medium-Term Thrust Areas 15% to 20% Borosil Investor presentation - Q2FY22 24

  26. Slide 26: Scientific Division

    BOROSII: , I . • • • -9 Borosil Investor presentation - Q2FY22 25

  27. Slide 27: Lab Instrumentation

    Lab Instrumentation Magnetic Stirrer Glass vials Burettes Block Digester Glass ampoules Pipettes Multi-Tube Vortexer Liquid handling systems Borosil Investor presentation - Q2FY22 26

  28. Slide 28: Scientific products market overview

    Lab Glassware Lab Pharma Packaging Lab Glassware India Exports Instrumentation (Vials & Ampoules) Market Size (INR Cr) 235 4000 200 1100 Est. Market Growth ~8-10% ~2-3% ~8-10% ~10-12% Customers Pharma R&D & QC, Pharma R&D & QC Pharma R&D & QC, Pharma cos Government Labs, Government Labs, Food & Soil

  29. Slide 29: Scientific Products Division Growth Theme

    Scientific Products Division Growth Theme Make in India - Build manufacturing capacity for Raw material –Tubing production New product development Substantially enhance capacity for Ampoules and Vials production Borosil Investor presentation - Q2FY22 28

  30. Slide 30: Some key Customers

    Some key Customers Borosil Investor presentation - Q2FY22 29

  31. Slide 31: Growth Pillars

    Growth Pillars International Core laboratory Become 2nd credible Borosil Investor presentation - Q2FY22 30

  32. Slide 32: Medium-Term Thrust Areas

    Medium-Term Thrust Areas ~15 Maintain EBITDA Margins Borosil Investor presentation - Q2FY22 31

  33. Slide 33: Laboratory Glassware

    Laboratory Glassware -- Meeting wide product range need of customer -- -- - Single supplier convenient for laboratory for multiple critical yet low ticket SKUs - - Not easily replicable by competition Quick & on-time delivery of SKU range - Investment in inventory, 6 warehouses & dealer network - We

  34. Slide 34: Primary Packaging for Pharma

    Primary Packaging for Pharma Glass Ampoules & Tubular Glass Vials for packaging pharmaceutical products Complements Borosil’s analytical vials range (used in the lab) Provides Borosil’s Pharmaceutical Customers credible 2nd alternative for their packaging needs more entrants COVID 19 opening many ma

  35. Slide 35: Key Enablers & Capabilities in Consumer business

    Key Enablers & Capabilities in Consumer business Borosil Investor presentation - Q2FY22 34

  36. Slide 36: Shreevar Kheruka, Chairman

    Shreevar Kheruka Chairman Borosil Investor presentation - Q2FY22 35

  37. Slide 37: Shareholding pattern as on 30 Sep 2021

    11,41,19,467 1.8% 0.3% Other 1369812D:IN BOROLTD 543212 27.4% Others INR 2499 Cr Promoters as on - 30 Sep 2021 : Borosil Investor presentation - Q2FY22 36

  38. Slide 38: Investor Relations

    Borosil Limited 1101, Crescenzo,G-Block, Opposite MCA Club, Bandra Kurla Complex Bandra (East), Mumbai - 400 051. India www.borosil.com www.myborosil.com Investor Relations: (anand.sultania@borosil.com) Borosil Investor presentation - Q2FY22 37

  39. Slide 39: borosil.com | myborosil.com

    borosi/.com I myborosil.com -- -- -- r - " ' ' / -- -- l - " -- - l - - l -- - -- r -- " - - Borosil Investor presentation - Q2FY22 38

Borosil — Q2 FY22 Earnings Presentation on 6ix